Report cover image

Strategic Intelligence: Pharma M&A Deals Q3 2024 - Top Themes

Publisher GlobalData
Published Nov 01, 2024
Length 28 Pages
SKU # GBDT19388640

Description

Strategic Intelligence: Pharma M&A Deals Q3 2024 - Top Themes


Summary

This report analyzes the disruptive themes that have driven M&A activity in Q3 2024 in the pharma Sector.

The global pharma sector in Q3 2024 witnessed deals worth $35 billion, a decline of 3% compared to Q3 2023. In terms of deal volume, there was a rise of 11% to record 279 M&A deals in Q3 2024. The Pharma sector recorded 12 mega deals (defined as any deal valued at more than $1 billion) in Q3 2024, an increase of 71% compared to Q3 2023.

Scope
  • This report provides an overview of merger and acquisition activity globally in Q3 2024 in Pharma Sector
  • It identifies the themes driving most notable to deals announced in Q3 2024 in the Pharma Sector
Reasons to Buy
  • Companies who invest in the right themes become success stories; those who miss the big themes end up as failures. If you want to understand the themes that drive an industry, simply look at the list of recent mergers and acquisitions (M&A).
  • In this report we have listed down the most notable deals in pharma sector to make it easy for our clients to get a view of themes disrupting the sector and prepare for the future.

Table of Contents

28 Pages
Executive Summary
Review of Pharma M&A Market - Q3 2024
Top Pharma M&A Deals by Sector - Q3 2024
Pharma M&A Deals Analysis by Geography - Q3 2024
Top Themes Driving Pharma M&A Activity - Q3 2024
Appendix 1: Deal Selection Criteria
Appendix 2: Top Themes for 2024 in Pharma
Appendix 3: Thematic Research Methodology

Search Inside Report

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us